Concepedia

Kurt Ritter

KR

Statistics

Publications

16

Citations

1.2K

H-Index

15

Active since

1985

Affiliations

Sanofi (Germany)(Current)

Sanofi (France)

Abbott (United States)

Heidelberg University

Kurt Ritter is an author at Sanofi (Germany) specializing in pharmacy, pharmacology, and medicinal chemistry.

Publications per year

1985–2013

16

Publications

16

Synthetic Transformations of Vinyl and Aryl Triflates

Kurt Ritter · Synthesis · 1993 · 389 citations

, , +15

Evidence for CCl/CBr⋅⋅⋅π Interactions as an Important Contribution to Protein–Ligand Binding Affinity

Hans Matter, Marc Nazaré, Stefan Güssregen et al. · Angewandte Chemie International Edition · 2009 · 270 citations

, , +17

Probing the Subpockets of Factor Xa Reveals Two Binding Modes for Inhibitors Based on a 2-Carboxyindole Scaffold:  A Study Combining Structure-Activity Relationship and X-ray Crystallography

Marc Nazaré, David W. Will, Hans Matter et al. · Journal of Medicinal Chemistry · 2005 · 119 citations · Full text

, , +12

Pyrazolo[3,4-d]pyrimidines containing an extended 3-substituent as potent inhibitors of Lck — a selectivity insight

Andrew Burchat, David J. Calderwood, Michael Friedman et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 76 citations · Full text

, , +13

Fragment Deconstruction of Small, Potent Factor Xa Inhibitors: Exploring the Superadditivity Energetics of Fragment Linking in Protein–Ligand Complexes

Marc Nazaré, Hans Matter, David W. Will et al. · Angewandte Chemie International Edition · 2011 · 57 citations

, , +13

1–5 of 16